UnitedHealth Group (NYSE:UNH) Stock Sold Off by Rep. Maria Elvira Salazar

Key Points

• Rep. Maria Elvira Salazar sold between $1,001 and $15,000 of UnitedHealth Group shares on September 24 from her UBS IRA account, alongside similarly sized sales of shares in several other companies.
• UnitedHealth reported quarterly EPS of $6.38, beating estimates of $4.94, on $112.03 billion in revenue. The company also maintained 2026 EPS guidance of $19.50–$20.00 and pays an annualized dividend of $9.28 per share.
• UNH shares opened at $370.54, below their 50-day and 200-day moving averages, while analysts retain a consensus “Moderate Buy” rating with a $465.75 price target. Investors remain focused on upcoming earnings, medical costs, Medicare trends and full-year guidance.

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on October 7th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on September 24th. The trade occurred in the Representative's "UBS IRA ACCOUNT" account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Citigroup NYSE: C on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 9/24/2026.
• Sold $1,001 - $15,000 in shares of GE Aerospace NYSE: GE on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Honeywell International NASDAQ: HON on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 9/24/2026.
• Sold $1,001 - $15,000 in shares of FedEx NYSE: FDX on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 9/24/2026.
• Sold $1,001 - $15,000 in shares of RH NYSE: RH on 9/24/2026.
• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 9/24/2026.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $370.54 on Friday. The company's fifty day simple moving average is $389.50 and its 200-day simple moving average is $380.30. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a market cap of $332.59 billion, a PE ratio of 23.84, a P/E/G ratio of 1.41 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the prior year, the firm earned $4.08 EPS. The firm's quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 19.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is presently 59.72%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is expected to report third-quarter earnings of roughly $4.12–$4.15 per share on revenue of approximately $111.38 billion. Forecast earnings growth of about 41% reflects expectations for benefits from cost management and restructuring, although revenue growth may remain subdued. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: Analysts and investors are increasingly viewing UnitedHealth’s reduced price-to-earnings valuation as potentially attractive after a difficult period marked by elevated medical costs and pressure across parts of the business. A successful earnings recovery could support a re-rating. UnitedHealth’s P/E Has Reset
• Neutral Sentiment: A Medicare rate decision could provide greater visibility into reimbursement trends and help stabilize expectations for UnitedHealth’s Medicare Advantage operations, but the longer-term effect will depend on medical-cost performance and membership trends. Does a Medicare Rate Decision Steady UnitedHealth Group?
• Neutral Sentiment: Market attention is concentrated on Q3 metrics beyond earnings and revenue, including medical loss ratios, Medicare membership, operating costs and management’s full-year guidance. These factors are likely to determine whether the anticipated earnings rebound is sustainable. UnitedHealth Q3 Earnings Key Metrics
• Negative Sentiment: The stock has underperformed the broader market and is testing an important support level before earnings, signaling investor caution and leaving the shares vulnerable to further weakness if results or guidance disappoint. UnitedHealth Stock Testing Key Support
• Negative Sentiment: A law firm is soliciting UnitedHealth shareholders regarding potential fiduciary-duty issues involving company insiders. The announcement does not establish wrongdoing, but it adds headline and litigation risk ahead of earnings. Shareholder Fiduciary-Duty Inquiry

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. State Street Corp raised its position in shares of UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock worth $18,966,555,000 after purchasing an additional 301,081 shares during the period. Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock valued at $4,449,317,000 after purchasing an additional 616,723 shares during the period. Wellington Management Group LLP lifted its position in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock valued at $4,436,923,000 after purchasing an additional 583,536 shares during the last quarter. Finally, Corient Private Wealth LP grew its position in UnitedHealth Group by 1,443.7% in the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after purchasing an additional 7,900,011 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Barclays boosted their price target on UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a research report on Monday, July 20th. Weiss Ratings cut shares of UnitedHealth Group from a "hold (c)" rating to a "hold (c-)" rating in a research report on Tuesday, July 28th. Mizuho lifted their price target on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a research note on Monday, July 20th. HSBC raised their target price on UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a research note on Monday, July 6th. Finally, UBS Group increased their price target on UnitedHealth Group from $460.00 to $490.00 and gave the company a "buy" rating in a report on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $465.75.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.19% of the company's stock.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida's 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida's 27th Congressional District. She won in the general election on November 5, 2024. Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.